首页 | 本学科首页   官方微博 | 高级检索  
     


Primary Immunodeficiency Diseases in Latin America: The Second Report of the LAGID Registry
Authors:LILY E. LEIVA  MARTA ZELAZCO  MATÍAS OLEASTRO  MAGDA CARNEIRO-SAMPAIO  ANTONIO CONDINO-NETO  BEATRIZ TAVARES COSTA-CARVALHO  ANETE SEVCIOVIC GRUMACH  ARNOLDO QUEZADA  PABLO PATIÑO  JOSÉ LUIS FRANCO  OSCAR PORRAS  FRANCISCO JAVIER RODRÍGUEZ  FRANCISCO JAVIER ESPINOSA-ROSALES  SARA ELVA ESPINOSA-PADILLA  DIVA ALMILLATEGUI  CELIA MARTÍNEZ  JUAN RODRÍGUEZ TAFUR  MARILYN VALENTÍN  LORENA BENARROCH  ROSY BARROSO  RICARDO U. SORENSEN
Affiliation:Department of Pediatrics, LSU Health Sciences Center, New Orleans, Louisiana, USA. lleiva@lsuhsc.edu
Abstract:
This is the second report on the continuing efforts of LAGID to increase the recognition and registration of patients with primary immunodeficiency diseases in 12 Latin American countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Honduras, Mexico, Panama, Paraguay, Peru, Uruguay, and Venezuela. This report reveals that from a total of 3321 patients registered, the most common form of primary immunodeficiency disease was predominantly antibody deficiency (53.2%) with IgA deficiency reported as the most frequent phenotype. This category was followed by 22.6% other well-defined ID syndromes, 9.5% combined T- and B-cell inmunodeficiency, 8.6% phagocytic disorders, 3.3% diseases of immune dysregulation, and 2.8% complement deficiencies. All countries that participated in the first publication in 1998 reported an increase in registered primary immunodeficiency cases, ranging between 10 and 80%. A comparison of the estimated minimal incidence of X-linked agammaglobulinemia, chronic granulomatous disease, and severe combined immunodeficiency between the first report and the present one shows an increase in the reporting of these diseases in all countries. In this report, the estimated minimal incidence of chronic granulomatous disease was between 0.72 and 1.26 cases per 100,000 births in Argentina, Chile, Costa Rica, and Uruguay and the incidence of severe combined immunodeficiency was 1.28 and 3.79 per 100,000 births in Chile and Costa Rica, respectively. However, these diseases are underreported in other participating countries. In addition to a better diagnosis of primary immunodeficiency diseases, more work on improving the registration of patients by each participating country and by countries that have not yet joined LAGID is still needed. Latin American Group for Primary Immunodeficiency Diseases
Keywords:Primary immunodeficiency  Latin America  LAGID  Immunodeficiency epidemiology
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号